This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
Login
News
In depth
Views
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Country profiles
Events
Sponsored
Newsletter
Hospital Pharmacy Europe
Rheumatology
Expert analysis: The importance of serological markers and serodiagnostics in RA
Read more
European Medicines Agency accepts extension MAA for review of Remsima SC
Read more
NHS on track to make £300m in savings after arthritis drug deals
Read more
Optimising management of systemic lupus erythematosus
Read more
JAK inhibitors in the treatment of rheumatoid arthritis
Read more
Treating giant cell arteritis
Read more
Challenges in the management of psoriatic arthritis
Read more
Sobi launches new treatment for patients with rare inflammatory diseases
Read more
New treatment for patients with rare inflammatory diseases
Read more
Anakinra receives positive opinion from CHMP for the treatment of Still’s disease
Read more
A promising new drug to combat serious inflammatory disease
Read more
Adalimumab biosimilar approved in Europe for the treatment of multiple chronic inflammatory diseases
Read more
First patient randomised in study evaluating safety and efficacy of anakinra in Still’s disease
Read more
Efficacy and safety maintained in patients who switched from Humira to biosimilar
Read more
Positive CHMP opinion for adalimumab biosimilar
Read more
Sarilumab approved for the treatment of moderately to severely active rheumatoid arthritis in adults
Read more
Data support the efficacy and safety of biosimilar rituximab in autoimmune disease and oncology
Read more
Page 7 of 9
« First
«
...
5
6
7
8
9
»
Popular articles
New protocol for IBD referral triage reduces diagnostic delays, say researchers
24 April, 2024
Bimekizumab gains EC approval for hidradenitis suppurativa
22 April, 2024
Semaglutide shows promise in patients with type 2 diabetes and obesity-related heart failure
22 April, 2024
x
Search for: